Preclinical Research of mμSORS for Noninvasive Blood Glucose Detection
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT05921344
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT05921344
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05921344. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-07-11 (actual); primary completion 2023-09-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Preclinical Research of mμSORS for Noninvasive Blood Glucose Detection
- Condition
- Type 2 Diabetes
- Condition
- Medical Device
- Intervention (Device)
- Multi-channel Microspatial Offset Raman Scattering Spectroscopy (mμSORS) for Noninvasive Blood Glucose Detection
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Collaborator
- Shanghai Photonic View Technology Co., Ltd.
Record details
- Record id
cardio:ct-nct05921344- Content hash
1df096b9af74f1f00ffaf5a2f50a436617a71a230cd9b865178c2e0fa30f9cf3